Tariff Impact on Drugs: Navigating Challenges i...

By Rene Pretorius

February 12, 2025

This article reviews industry responses to the potential impact of a 10% tariff imposed by the U.S. government on Chinese imports, particularly on the generic and biosimilar drug market. The tariff impact on drugs may lea...
AI Decision Support in Aortic Stenosis Detection
Bioelectronic Medicine Innovations: Advancing Non-Invasive Neuromodulation St...
FDA Grants Datopotamab Deruxtecan Approval for HR-Positive Breast Cancer Trea...
Trump Healthcare Policy Changes: Reversing Biden’s Executive Orders and...
U.S. Withdraws from WHO: Impact on Global Health Security and Relations
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Pharmaceutical Data Collaboration Between Canada’s Drug Agency and CIHI
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Zepbound Outperforms Wegovy in Weight Loss Trial
Canada’s Drug Agency Launches Consultation on New Methods Guide for Hea...